Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-19-003976

Chief Financial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Raines Heather Chief Financial Officer 2019-03-25 Grant or award +50,000 1,163,153 D
Loading xslF345X03/ownership.xml…